🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This phase I trial is studying the side effects and best dose of combinatio...
Status
Completed
Location
Memorial Sloan-Kettering Cancer Center
Start Date
2003-02
Trial ID
NCT00058253
Treatments Being Tested
The purpose of this study is to see if IPI-504 in combination with trastuza...
Status
Terminated
Location
Comprehensive Cancer Center at Desert Regional Medical Center
Start Date
2009-03
Trial ID
NCT00817362
Treatments Being Tested
RATIONALE: Drugs used in chemotherapy, such as 17-N-allylamino-17-demethoxy...
Status
Completed
Location
Memorial Sloan-Kettering Cancer Center
Start Date
2004-08
Trial ID
NCT00093405
Treatments Being Tested
This phase I trial is studying the side effects and best dose of tanespimyc...
Status
Completed
Location
Mayo Clinic
Start Date
2004-11
Trial ID
NCT00098423
Treatments Being Tested
This phase I trial is studying the side effects and best dose of 17-N-allyl...
Status
Completed
Location
University of Pennsylvania Medical Center
Start Date
2004-05
Trial ID
NCT00087217
Treatments Being Tested
This phase I trial is studying the side effects and best dose of 17-N-allyl...
Status
Completed
Location
COG Phase I Consortium
Start Date
2004-03
Trial ID
NCT00079404
Treatments Being Tested
This phase I trial studies the side effects, best way to give, and best dos...
Status
Completed
Location
Mayo Clinic
Start Date
2002-08
Trial ID
NCT00047047
Treatments Being Tested
RATIONALE: Imatinib mesylate may stop the growth of cancer cells by blockin...
Status
Completed
Location
Barbara Ann Karmanos Cancer Institute
Start Date
2003-06
Trial ID
NCT00066326
Treatments Being Tested
RATIONALE: Drugs used in chemotherapy, such as 17-N-allylamino-17-demethoxy...
Status
Completed
Location
Warren Grant Magnuson Clinical Center - NCI Clinical Trials Referral Office
Start Date
2006-05
Trial ID
NCT00132015
Treatments Being Tested
This phase II trial is studying how well tanespimycin works in treating pat...
Status
Completed
Location
Mayo Clinic
Start Date
2004-12
Trial ID
NCT00118248
Treatments Being Tested